5432202022-04-012022-09-305432202022-09-305432202022-04-012022-09-30RelatedPartyTransactionDomain15432202022-03-31RelatedPartyTransactionDomain15432202022-09-30RelatedPartyTransactionDomain15432202022-04-012022-09-30RelatedPartyTransactionDomain25432202022-03-31RelatedPartyTransactionDomain25432202022-09-30RelatedPartyTransactionDomain25432202022-04-012022-09-30RelatedPartyTransactionDomain35432202022-03-31RelatedPartyTransactionDomain35432202022-09-30RelatedPartyTransactionDomain35432202022-04-012022-09-30RelatedPartyTransactionDomain45432202022-03-31RelatedPartyTransactionDomain45432202022-09-30RelatedPartyTransactionDomain45432202022-04-012022-09-30RelatedPartyTransactionDomain55432202022-03-31RelatedPartyTransactionDomain55432202022-09-30RelatedPartyTransactionDomain55432202022-04-012022-09-30RelatedPartyTransactionDomain65432202022-03-31RelatedPartyTransactionDomain65432202022-09-30RelatedPartyTransactionDomain65432202022-04-012022-09-30RelatedPartyTransactionDomain75432202022-03-31RelatedPartyTransactionDomain75432202022-09-30RelatedPartyTransactionDomain75432202022-04-012022-09-30RelatedPartyTransactionDomain85432202022-03-31RelatedPartyTransactionDomain85432202022-09-30RelatedPartyTransactionDomain85432202022-04-012022-09-30RelatedPartyTransactionDomain95432202022-03-31RelatedPartyTransactionDomain95432202022-09-30RelatedPartyTransactionDomain95432202022-04-012022-09-30RelatedPartyTransactionDomain105432202022-03-31RelatedPartyTransactionDomain105432202022-09-30RelatedPartyTransactionDomain105432202022-04-012022-09-30RelatedPartyTransactionDomain115432202022-03-31RelatedPartyTransactionDomain115432202022-09-30RelatedPartyTransactionDomain115432202022-04-012022-09-30RelatedPartyTransactionDomain125432202022-03-31RelatedPartyTransactionDomain125432202022-09-30RelatedPartyTransactionDomain125432202022-04-012022-09-30RelatedPartyTransactionDomain135432202022-03-31RelatedPartyTransactionDomain135432202022-09-30RelatedPartyTransactionDomain135432202022-04-012022-09-30RelatedPartyTransactionDomain145432202022-03-31RelatedPartyTransactionDomain145432202022-09-30RelatedPartyTransactionDomain145432202022-04-012022-09-30RelatedPartyTransactionDomain155432202022-03-31RelatedPartyTransactionDomain155432202022-09-30RelatedPartyTransactionDomain155432202022-04-012022-09-30RelatedPartyTransactionDomain165432202022-03-31RelatedPartyTransactionDomain165432202022-09-30RelatedPartyTransactionDomain165432202022-04-012022-09-30RelatedPartyTransactionDomain175432202022-03-31RelatedPartyTransactionDomain175432202022-09-30RelatedPartyTransactionDomain175432202022-04-012022-09-30RelatedPartyTransactionDomain185432202022-03-31RelatedPartyTransactionDomain185432202022-09-30RelatedPartyTransactionDomain185432202022-04-012022-09-30RelatedPartyTransactionDomain195432202022-03-31RelatedPartyTransactionDomain195432202022-09-30RelatedPartyTransactionDomain195432202022-04-012022-09-30RelatedPartyTransactionDomain205432202022-03-31RelatedPartyTransactionDomain205432202022-09-30RelatedPartyTransactionDomain205432202022-04-012022-09-30RelatedPartyTransactionDomain215432202022-03-31RelatedPartyTransactionDomain215432202022-09-30RelatedPartyTransactionDomain215432202022-04-012022-09-30RelatedPartyTransactionDomain225432202022-03-31RelatedPartyTransactionDomain225432202022-09-30RelatedPartyTransactionDomain225432202022-04-012022-09-30RelatedPartyTransactionDomain235432202022-03-31RelatedPartyTransactionDomain235432202022-09-30RelatedPartyTransactionDomain235432202022-04-012022-09-30RelatedPartyTransactionDomain245432202022-03-31RelatedPartyTransactionDomain245432202022-09-30RelatedPartyTransactionDomain245432202022-04-012022-09-30RelatedPartyTransactionDomain255432202022-03-31RelatedPartyTransactionDomain255432202022-09-30RelatedPartyTransactionDomain255432202022-04-012022-09-30RelatedPartyTransactionDomain265432202022-03-31RelatedPartyTransactionDomain265432202022-09-30RelatedPartyTransactionDomain265432202022-04-012022-09-30RelatedPartyTransactionDomain275432202022-03-31RelatedPartyTransactionDomain275432202022-09-30RelatedPartyTransactionDomain275432202022-04-012022-09-30RelatedPartyTransactionDomain285432202022-03-31RelatedPartyTransactionDomain285432202022-09-30RelatedPartyTransactionDomain285432202022-04-012022-09-30RelatedPartyTransactionDomain295432202022-03-31RelatedPartyTransactionDomain295432202022-09-30RelatedPartyTransactionDomain295432202022-04-012022-09-30RelatedPartyTransactionDomain305432202022-03-31RelatedPartyTransactionDomain305432202022-09-30RelatedPartyTransactionDomain305432202022-04-012022-09-30RelatedPartyTransactionDomain315432202022-03-31RelatedPartyTransactionDomain315432202022-09-30RelatedPartyTransactionDomain315432202022-04-012022-09-30RelatedPartyTransactionDomain325432202022-03-31RelatedPartyTransactionDomain325432202022-09-30RelatedPartyTransactionDomain325432202022-04-012022-09-30RelatedPartyTransactionDomain335432202022-03-31RelatedPartyTransactionDomain335432202022-09-30RelatedPartyTransactionDomain335432202022-04-012022-09-30RelatedPartyTransactionDomain345432202022-03-31RelatedPartyTransactionDomain345432202022-09-30RelatedPartyTransactionDomain345432202022-04-012022-09-30RelatedPartyTransactionDomain355432202022-03-31RelatedPartyTransactionDomain355432202022-09-30RelatedPartyTransactionDomain355432202022-04-012022-09-30RelatedPartyTransactionDomain365432202022-03-31RelatedPartyTransactionDomain365432202022-09-30RelatedPartyTransactionDomain365432202022-04-012022-09-30RelatedPartyTransactionDomain375432202022-03-31RelatedPartyTransactionDomain375432202022-09-30RelatedPartyTransactionDomain375432202022-04-012022-09-30RelatedPartyTransactionDomain385432202022-03-31RelatedPartyTransactionDomain385432202022-09-30RelatedPartyTransactionDomain385432202022-04-012022-09-30RelatedPartyTransactionDomain395432202022-03-31RelatedPartyTransactionDomain395432202022-09-30RelatedPartyTransactionDomain395432202022-04-012022-09-30RelatedPartyTransactionDomain405432202022-03-31RelatedPartyTransactionDomain405432202022-09-30RelatedPartyTransactionDomain405432202022-04-012022-09-30RelatedPartyTransactionDomain415432202022-03-31RelatedPartyTransactionDomain415432202022-09-30RelatedPartyTransactionDomain415432202022-04-012022-09-30RelatedPartyTransactionDomain425432202022-03-31RelatedPartyTransactionDomain425432202022-09-30RelatedPartyTransactionDomain425432202022-04-012022-09-30RelatedPartyTransactionDomain435432202022-03-31RelatedPartyTransactionDomain435432202022-09-30RelatedPartyTransactionDomain435432202022-04-012022-09-30RelatedPartyTransactionDomain445432202022-03-31RelatedPartyTransactionDomain445432202022-09-30RelatedPartyTransactionDomain445432202022-04-012022-09-30RelatedPartyTransactionDomain455432202022-03-31RelatedPartyTransactionDomain455432202022-09-30RelatedPartyTransactionDomain455432202022-04-012022-09-30RelatedPartyTransactionDomain465432202022-03-31RelatedPartyTransactionDomain465432202022-09-30RelatedPartyTransactionDomain465432202022-04-012022-09-30RelatedPartyTransactionDomain475432202022-03-31RelatedPartyTransactionDomain475432202022-09-30RelatedPartyTransactionDomain475432202022-04-012022-09-30RelatedPartyTransactionDomain485432202022-03-31RelatedPartyTransactionDomain485432202022-09-30RelatedPartyTransactionDomain485432202022-04-012022-09-30RelatedPartyTransactionDomain495432202022-03-31RelatedPartyTransactionDomain495432202022-09-30RelatedPartyTransactionDomain495432202022-04-012022-09-30RelatedPartyTransactionDomain505432202022-03-31RelatedPartyTransactionDomain505432202022-09-30RelatedPartyTransactionDomain505432202022-04-012022-09-30RelatedPartyTransactionDomain515432202022-03-31RelatedPartyTransactionDomain515432202022-09-30RelatedPartyTransactionDomain515432202022-04-012022-09-30RelatedPartyTransactionDomain525432202022-03-31RelatedPartyTransactionDomain525432202022-09-30RelatedPartyTransactionDomain525432202022-04-012022-09-30RelatedPartyTransactionDomain535432202022-03-31RelatedPartyTransactionDomain535432202022-09-30RelatedPartyTransactionDomain535432202022-04-012022-09-30RelatedPartyTransactionDomain545432202022-03-31RelatedPartyTransactionDomain545432202022-09-30RelatedPartyTransactionDomain545432202022-04-012022-09-30RelatedPartyTransactionDomain555432202022-03-31RelatedPartyTransactionDomain555432202022-09-30RelatedPartyTransactionDomain555432202022-04-012022-09-30RelatedPartyTransactionDomain565432202022-03-31RelatedPartyTransactionDomain565432202022-09-30RelatedPartyTransactionDomain565432202022-04-012022-09-30RelatedPartyTransactionDomain575432202022-03-31RelatedPartyTransactionDomain575432202022-09-30RelatedPartyTransactionDomain575432202022-04-012022-09-30RelatedPartyTransactionDomain585432202022-03-31RelatedPartyTransactionDomain585432202022-09-30RelatedPartyTransactionDomain585432202022-04-012022-09-30RelatedPartyTransactionDomain595432202022-03-31RelatedPartyTransactionDomain595432202022-09-30RelatedPartyTransactionDomain595432202022-04-012022-09-30RelatedPartyTransactionDomain605432202022-03-31RelatedPartyTransactionDomain605432202022-09-30RelatedPartyTransactionDomain605432202022-04-012022-09-30RelatedPartyTransactionDomain615432202022-03-31RelatedPartyTransactionDomain615432202022-09-30RelatedPartyTransactionDomain615432202022-04-012022-09-30RelatedPartyTransactionDomain625432202022-03-31RelatedPartyTransactionDomain625432202022-09-30RelatedPartyTransactionDomain625432202022-04-012022-09-30RelatedPartyTransactionDomain635432202022-03-31RelatedPartyTransactionDomain635432202022-09-30RelatedPartyTransactionDomain635432202022-04-012022-09-30RelatedPartyTransactionDomain645432202022-03-31RelatedPartyTransactionDomain645432202022-09-30RelatedPartyTransactionDomain645432202022-04-012022-09-30RelatedPartyTransactionDomain655432202022-03-31RelatedPartyTransactionDomain655432202022-09-30RelatedPartyTransactionDomain655432202022-04-012022-09-30RelatedPartyTransactionDomain665432202022-03-31RelatedPartyTransactionDomain665432202022-09-30RelatedPartyTransactionDomain665432202022-04-012022-09-30RelatedPartyTransactionDomain675432202022-03-31RelatedPartyTransactionDomain675432202022-09-30RelatedPartyTransactionDomain675432202022-04-012022-09-30RelatedPartyTransactionDomain685432202022-03-31RelatedPartyTransactionDomain685432202022-09-30RelatedPartyTransactionDomain685432202022-04-012022-09-30RelatedPartyTransactionDomain695432202022-03-31RelatedPartyTransactionDomain695432202022-09-30RelatedPartyTransactionDomain69iso4217:INRxbrli:pureMAX HEALTHCARE INSTITUTE LIMITED543220MAXHEALTHNOTLISTED2022-04-012023-03-31First half yearly2022-04-012022-09-30LakhstruetrueNANAfalsefalseMax Healthcare Institute LimitedCrosslay Remedies LimitedSubsidiaryAny other transactionInvestment in equity sharesAs per approval given by Audit & Risk Management Committee044913000004496100000<DIV > <P>1. All transactions with related parties&nbsp;being reported are excluding of taxes and are made on terms equivalent to those that prevail in arm's length transactions. </P> <P>2. The value of the related party transactions denotes the amount approved by the Audit &amp; Risk Managemement Committee/ Board of Directors of the Company, as applicable, for financial year 2022-23.</P> <P>3. Crosslay Remedies Limited became wholly-owned subsidiary w.e.f. June 03, 2022. However, transaction reported for full period i.e. from April 01, 2022 to Sep 30, 2022. </P> <DIV></DIV></DIV>Max Healthcare Institute LimitedCrosslay Remedies LimitedSubsidiaryAny other transactionDeemed investment on account of grant of stock options to the employees of the subsidiary company under Max Healthcare Insititute Limited - Employee Stock Options Plan 2020 in terms of IND AS 1022300000As per approval given by Audit & Risk Management Committee23000002730000029600000<DIV >Crosslay Remedies Limited became wholly-owned subsidiary w.e.f. June 03, 2022. However, transaction reported for full period i.e. from April 01, 2022 to Sep 30, 2022. <DIV></DIV></DIV>Max Healthcare Institute LimitedCrosslay Remedies LimitedSubsidiarySale of goods or services150000000As per approval given by Audit & Risk Management Committee25000002400000500000<DIV >1. Crosslay Remedies Limited became wholly-owned subsidiary w.e.f. June 03, 2022. However,&nbsp; transaction reported for full period i.e. from April 01, 2022 to Sep 30, 2022. <DIV>&nbsp;</DIV> <DIV>2. Audit Committee Approval of&nbsp;INR 1,500 Lac&nbsp;pertains to Serial No. 3&nbsp;&amp; 4.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Opening Balance of&nbsp;INR 24 lac pertains to Serial No. 3 to 9.</DIV> <DIV>&nbsp;</DIV> <DIV>4. Closing Balance of&nbsp;INR&nbsp;5 lac pertains to Serial No. 3 to 9.</DIV> <DIV>&nbsp;</DIV></DIV>Max Healthcare Institute LimitedCrosslay Remedies LimitedSubsidiaryPurchase of goods or servicesAs per approval given by Audit & Risk Management Committee840000000<DIV >1. Crosslay Remedies Limited became wholly-owned subsidiary w.e.f. June 03, 2022. However, transaction reported for full period i.e. from April 01, 2022 to Sep 30, 2022. <DIV>&nbsp;</DIV> <DIV> <DIV>2. Audit Committee Approval of&nbsp;INR 1,500 Lac&nbsp;pertains to Serial No. 3&nbsp;&amp; 4.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Opening Balance of&nbsp;INR 24 lac pertains to Serial No. 3 to 9.</DIV> <DIV>&nbsp;</DIV> <DIV>4. Closing Balance of&nbsp;INR&nbsp;5 lac pertains to Serial No. 3 to 9.</DIV></DIV></DIV>Max Healthcare Institute LimitedCrosslay Remedies LimitedSubsidiarySale of goods or services180000000As per approval given by Audit & Risk Management Committee3190000000<DIV > <DIV></DIV> <P>1. Crosslay Remedies Limited became wholly-owned subsidiary w.e.f. June 03, 2022. However, transaction reported for full period i.e. from April 01, 2022 to Sep 30, 2022.</P> <DIV>2. Audit Committee Approval of&nbsp;INR 1,800 Lac&nbsp;pertains to Serial No.&nbsp;5&nbsp;&amp; 6.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Opening Balance of&nbsp;INR 24 lac pertains to Serial No. 3 to 9.</DIV> <DIV>&nbsp;</DIV> <DIV>4. Closing Balance of&nbsp;INR&nbsp;5 lac pertains to Serial No. 3 to 9.</DIV></DIV>Max Healthcare Institute LimitedCrosslay Remedies LimitedSubsidiaryPurchase of goods or servicesAs per approval given by Audit & Risk Management Committee860000000<DIV > <P>1. Crosslay Remedies Limited became wholly-owned subsidiary w.e.f. June 03, 2022. However, transaction reported for full period i.e. from April 01, 2022 to Sep 30, 2022.</P> <DIV>2. Audit Committee Approval of&nbsp;INR 1,800 Lac&nbsp;pertains to Serial No.&nbsp;5&nbsp;&amp; 6.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Opening Balance of&nbsp;INR 24 lac pertains to Serial No. 3 to 9.</DIV> <DIV>&nbsp;</DIV> <DIV>4. Closing Balance of&nbsp;INR&nbsp;5 lac pertains to Serial No. 3 to 9.</DIV></DIV>Max Healthcare Institute LimitedCrosslay Remedies LimitedSubsidiaryAny other transactionFinance Arrangement fee received9000000As per approval given by Audit & Risk Management Committee320000000<DIV > <P>1. Crosslay Remedies Limited became wholly-owned subsidiary w.e.f. June 03, 2022. However, transaction reported for full period i.e. from April 01, 2022 to Sep 30, 2022.</P> <DIV>2. Opening Balance of&nbsp;INR 24 lac pertains to Serial No. 3 to 9.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Closing Balance of&nbsp;INR&nbsp;5 lac pertains to Serial No. 3 to 9.</DIV></DIV>Max Healthcare Institute LimitedCrosslay Remedies LimitedSubsidiaryAny other transactionSpace taken on lease rent200000As per approval given by Audit & Risk Management Committee10000000<DIV > <P>1. Crosslay Remedies Limited became wholly-owned subsidiary w.e.f. June 03, 2022. However, transaction reported for full period i.e. from April 01, 2022 to Sep 30, 2022.</P> <DIV>2. Opening Balance of&nbsp;INR 24 lac pertains to Serial No. 3 to 9.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Closing Balance of&nbsp;INR&nbsp;5 lac pertains to Serial No. 3 to 9.</DIV></DIV>Max Healthcare Institute LimitedCrosslay Remedies LimitedSubsidiaryAny other transactionRental income from sub- leasing of property300000As per approval given by Audit & Risk Management Committee14000000<DIV > <P>1. Crosslay Remedies Limited became wholly-owned subsidiary w.e.f. June 03, 2022. However, transaction reported for full period i.e. from April 01, 2022 to Sep 30, 2022.</P> <DIV>2. Opening Balance of&nbsp;INR 24 lac pertains to Serial No. 3 to 9.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Closing Balance of&nbsp;INR&nbsp;5 lac pertains to Serial No. 3 to 9.</DIV></DIV>Max Healthcare Institute LimitedCrosslay Remedies LimitedSubsidiaryInterest paid75000000As per approval given by Audit & Risk Management Committee14000000305200000304900000<DIV > <P>1. Crosslay Remedies Limited became wholly-owned subsidiary w.e.f. June 03, 2022. However, transaction reported for full period i.e. from April 01, 2022 to Sep 30, 2022.</P> <DIV>2. Opening Balance of&nbsp;INR&nbsp;3052 lac pertains to Serial No.&nbsp;10&nbsp;&amp; 11.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Closing Balance of&nbsp;INR&nbsp;3049 lac pertains to Serial No.&nbsp;10&nbsp;&amp; 11.</DIV> <P>4. Consequent to voluntary liquidation of Saket City Hospital Limited (“SCHL”) under the provisions of Insolvency and Bankruptcy Code, 2016, business undertaking of SCHL was distributed to the Company on a going concern basis on August 31, 2022 which included loan taken by SCHL from Crosslay Remedies Limited, fellow subsidiary. The said loan of SCHL has thus now reflected in the books of the Company as borrowing. </P> <P>5. Value of transaction related&nbsp;to interest paid also includes accured interest.&nbsp;&nbsp;</P></DIV>Max Healthcare Institute LimitedCrosslay Remedies LimitedSubsidiaryLoan500000000As per approval given by Audit & Risk Management Committee000Loan0.092510 YearUnsecuredFor general business corporate & capital expenditure<DIV > <P>1. Crosslay Remedies Limited became wholly-owned subsidiary w.e.f. June 03, 2022. However, transaction reported for full period i.e. from April 01, 2022 to Sep 30, 2022.</P> <DIV>2. Opening Balance of&nbsp;INR&nbsp;3052 lac pertains to Serial No.&nbsp;10&nbsp;&amp; 11.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Closing Balance of&nbsp;INR&nbsp;3049 lac pertains to Serial No.&nbsp;10&nbsp;&amp; 11.</DIV> <DIV>&nbsp;</DIV> <DIV>4. Consequent to voluntary liquidation of Saket City Hospital Limited (“SCHL”) under the provisions of Insolvency and Bankruptcy Code, 2016, business undertaking of SCHL was distributed to the Company on a going concern basis on August 31, 2022 which included loan taken by SCHL from Crosslay Remedies Limited, fellow subsidiary. The said loan of SCHL has thus now reflected in the books of the Company as borrowing. </DIV></DIV>Max Healthcare Institute LimitedCrosslay Remedies LimitedSubsidiaryAny other transactionEmployee benefit liability transferred-in5000000As per approval given by Audit & Risk Management Committee14000000<DIV >1. Crosslay Remedies Limited became wholly-owned subsidiary w.e.f. June 03, 2022. However,&nbsp; transaction reported for full period i.e. from April 01, 2022 to Sep 30, 2022. <DIV>&nbsp;</DIV> <DIV>2. Audit Committee Approval of&nbsp;INR&nbsp;50 Lac&nbsp;pertains to Serial No.&nbsp;12&nbsp;&amp; 13.</DIV></DIV>Max Healthcare Institute LimitedCrosslay Remedies LimitedSubsidiaryAny other transactionEmployee benefit liability transferred-outAs per approval given by Audit & Risk Management Committee3000000<DIV >1. Crosslay Remedies Limited became wholly-owned subsidiary w.e.f. June 03, 2022. However,&nbsp; transaction reported for full period i.e. from April 01, 2022 to Sep 30, 2022. <DIV>&nbsp;</DIV> <DIV>2. Audit Committee Approval of&nbsp;INR&nbsp;50 Lac&nbsp;pertains to Serial No.&nbsp;12&nbsp;&amp; 13.</DIV></DIV>Max Healthcare Institute LimitedCrosslay Remedies LimitedSubsidiaryAny other transactionCorporate Guarantee amount increased due to partial borrowing amount increased2400000000As per approval given by Audit & Risk Management Committee3170000013315000001363200000<DIV > <DIV>Crosslay Remedies Limited became wholly-owned subsidiary w.e.f. June 03, 2022. However, transaction reported for full period i.e. from April 01, 2022 to Sep 30, 2022.</DIV></DIV>Max Healthcare Institute LimitedEqova Healthcare Private LimitedSubsidiaryAny other transactionInvestment in equity sharesAs per approval given by Audit & Risk Management Committee0471800000471800000Max Healthcare Institute LimitedRadiant Life Care Private LimitedEntities under same Group/common controlAny other transactionLease rent expense300000As per approval given by Audit & Risk Management Committee1400000100000Max Healthcare Institute LimitedRadiant Life Care Private LimitedEntities under same Group/common controlAny other transactionReimbursement of electricity and other expenses20000As per approval given by Audit & Risk Management Committee2000000Max Healthcare Institute LimitedMr. Yogesh Kumar SareenKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee1990000000<DIV > <DIV></DIV> <P>1. As the future liability for gratuity and compensated absences is provided on an actuarial basis for the Company as a whole, the amount pertaining to the directors /KMPS has not been ascertained separately and, therefore, not included in&nbsp;transactions related to remuneration.&nbsp;Remuneration&nbsp;also do not include accrual recorded towards employee share based payments but includes benefit value on account of ESOP exercise during the reporting period.</P> <P>2. As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/ Shareholders, as may be applicable.</P></DIV>Max Healthcare Institute LimitedMr. Yogesh Kumar SareenKey Managerial PersonnelAny other transactionSecurity deposit received as per Company’s car policy for employeesAs per approval given by Audit & Risk Management Committee0400000400000<DIV > <DIV></DIV>As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable</DIV>Max Healthcare Institute LimitedMs. Ruchi MahajanKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee310000000<DIV > <DIV></DIV>As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable</DIV>Max Healthcare Institute LimitedMs. Ruchi MahajanKey Managerial PersonnelAny other transactionSecurity deposit received as per Company’s car policy for employeesAs per approval given by Audit & Risk Management Committee0300000300000<DIV > <DIV></DIV>As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable</DIV>Max Healthcare Institute LimitedMr. Abhay SoiDirector & Key Managerial Personnel (Chairman & Managing Director)RemunerationAs per approval given by Audit & Risk Management Committee7000000000<DIV >As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable <DIV></DIV></DIV>Max Healthcare Institute LimitedMr. Kummamuri Murthy NarasimhaIndependent DirectorAny other transactionDirector's sitting feeAs per approval given by Audit & Risk Management Committee1200000100000200000<DIV > <P>1. As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable.</P> <DIV>2. Opening Balance of&nbsp;INR&nbsp;1 lac pertains to Serial No. 23&nbsp;&amp; 24.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Closing Balance of&nbsp;INR&nbsp;2 lac pertains to Serial No. 23&nbsp;&amp; 24.</DIV> <DIV></DIV></DIV>Max Healthcare Institute LimitedMr. Kummamuri Murthy NarasimhaIndependent DirectorRemunerationAs per approval given by Audit & Risk Management Committee130000000<DIV > <P>1. As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable.</P> <DIV>2. Opening Balance of&nbsp;INR&nbsp;1 lac pertains to Serial No. 23&nbsp;&amp; 24.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Closing Balance of&nbsp;INR&nbsp;2 lac pertains to Serial No. 23&nbsp;&amp; 24.</DIV> <DIV>&nbsp;</DIV> <DIV>4. Remuneration pertains to&nbsp;Remuneration paid to Independent Director.</DIV></DIV>Max Healthcare Institute LimitedMs. Harmeen MehtaIndependent DirectorAny other transactionDirector's sitting feeAs per approval given by Audit & Risk Management Committee1200000400000100000<DIV > <P>1. As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable.</P> <DIV>2. Opening Balance of&nbsp;INR&nbsp;4 lac pertains to Serial No. 25&nbsp;&amp; 26.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Closing Balance of&nbsp;INR&nbsp;1 lac pertains to Serial No. 25&nbsp;&amp; 26.</DIV></DIV>Max Healthcare Institute LimitedMs. Harmeen MehtaIndependent DirectorRemunerationAs per approval given by Audit & Risk Management Committee130000000<DIV > <P>1. As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable.</P> <DIV>2. Opening Balance of&nbsp;INR&nbsp;4 lac pertains to Serial No. 25&nbsp;&amp; 26.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Closing Balance of&nbsp;INR&nbsp;1 lac pertains to Serial No. 25&nbsp;&amp; 26.</DIV> <DIV>&nbsp;</DIV> <DIV> <DIV>4. Remuneration pertains to&nbsp;Remuneration paid to Independent Director.</DIV></DIV></DIV>Max Healthcare Institute LimitedMr. Mahendra Gumanmalji LodhaIndependent DirectorAny other transactionDirector's sitting feeAs per approval given by Audit & Risk Management Committee13000000200000<DIV > <P>1. As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable.</P> <DIV>2. Closing Balance of&nbsp;INR&nbsp;2 lac pertains to Serial No. 27&nbsp;&amp; 28.</DIV></DIV>Max Healthcare Institute LimitedMr. Mahendra Gumanmalji LodhaIndependent DirectorRemunerationAs per approval given by Audit & Risk Management Committee130000000<DIV > <P>1. As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable.</P> <DIV>2. Closing Balance of&nbsp;INR&nbsp;2 lac pertains to Serial No. 27&nbsp;&amp; 28.</DIV> <DIV>&nbsp;</DIV> <DIV> <DIV>3. Remuneration pertains to&nbsp;Remuneration paid to Independent Director.</DIV></DIV></DIV>Max Healthcare Institute LimitedMr. Michael Thomas NeebIndependent DirectorAny other transactionDirector's sitting feeAs per approval given by Audit & Risk Management Committee900000400000300000<DIV > <P>1. As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable.</P> <DIV>2. Opening Balance of&nbsp;INR&nbsp;4 lac pertains to Serial No. 29&nbsp;&amp; 30.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Closing Balance of&nbsp;INR&nbsp;3 lac pertains to Serial No. 29&nbsp;&amp; 30.</DIV></DIV>Max Healthcare Institute LimitedMr. Michael Thomas NeebIndependent DirectorRemunerationAs per approval given by Audit & Risk Management Committee130000000<DIV > <P>1. As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable.</P> <DIV>2. Opening Balance of&nbsp;INR&nbsp;4 lac pertains to Serial No. 29&nbsp;&amp; 30.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Closing Balance of&nbsp;INR&nbsp;3 lac pertains to Serial No. 29&nbsp;&amp; 30.</DIV> <DIV>&nbsp;</DIV> <DIV> <DIV>4. Remuneration pertains to&nbsp;Remuneration paid to Independent Director.</DIV></DIV></DIV>Alps Hospital LimitedRadiant Life Care Private LimitedEntities under same Group/common controlAny other transactionLease rent expense100000As per approval given by Audit & Risk Management Committee5000000Alps Hospital LimitedRadiant Life Care Private LimitedEntities under same Group/common controlAny other transactionReimbursement of electricity and other expenses10000As per approval given by Audit & Risk Management Committee1000000Alps Hospital LimitedMs. Arpita MukherjeeWhole-time DirectorRemunerationAs per approval given by Audit & Risk Management Committee290000000<DIV >As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable <DIV></DIV></DIV>Alps Hospital LimitedMs. Arpita MukherjeeWhole-time DirectorAny other transactionSecurity Deposit received as per Company's car policy for employeesAs per approval given by Audit & Risk Management Committee0100000100000<DIV > <DIV>As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable </DIV></DIV>Alps Hospital LimitedMr. Anurag GuptaKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee70000000<DIV >As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable <DIV></DIV></DIV>Alps Hospital LimitedMr. Anurag GuptaKey Managerial PersonnelAny other transactionSecurity Deposit received as per Company's car policy for employeesAs per approval given by Audit & Risk Management Committee0100000100000<DIV > <DIV></DIV>As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable</DIV>Alps Hospital LimitedMs. RituKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee30000000<DIV >As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable <DIV></DIV></DIV>Crosslay Remedies LimitedMax Lab LimitedFellow SubsidiarySale of goods or services35000000As per approval given by Audit & Risk Management Committee30200000990000027800000Crosslay Remedies LimitedMax Lab LimitedFellow SubsidiaryAny other transactionEmployee benefit liability transferred-in5000000As per approval given by Audit & Risk Management Committee10000000Crosslay Remedies LimitedHometrail Buildtech Private LimitedFellow SubsidiaryAny other transactionEmployee benefit liability transferred-out5000000As per approval given by Audit & Risk Management Committee1000000100000Crosslay Remedies LimitedEqova Healthcare Private LimitedFellow SubsidiaryInterest received35000000As per approval given by Audit & Risk Management Committee12800000252800000264400000<DIV > <P>1. Opening Balance of&nbsp;INR&nbsp;2528 lac pertains to Serial No.&nbsp;41&nbsp;&amp; 42.</P> <DIV>2. Closing Balance of&nbsp;INR&nbsp;2644 lac pertains to Serial No. 41&nbsp;&amp; 42.</DIV> <DIV>&nbsp;</DIV> <DIV>3. Value of transaction related&nbsp;to interest received&nbsp;also includes accured interest.</DIV> <DIV></DIV></DIV>Crosslay Remedies LimitedEqova Healthcare Private LimitedFellow SubsidiaryLoan250000000As per approval given by Audit & Risk Management Committee000Loan0.10253 yearUnsecuredFor general business corporate & capital expenditure<DIV > <DIV> <P>1. Opening Balance of&nbsp;INR&nbsp;2528 lac pertains to Serial No.&nbsp;41&nbsp;&amp; 42.</P> <DIV>2. Closing Balance of&nbsp;INR&nbsp;2644 lac pertains to Serial No. 41&nbsp;&amp; 42.</DIV></DIV></DIV>Crosslay Remedies LimitedDr. B.L Kapur Memorial HospitalEntity under same Group/common controlAny other transactionEmployee benefit liability transferred-in5000000As per approval given by Audit & Risk Management Committee2000000100000Crosslay Remedies LimitedMr. Dhiraj SharmaKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee160000000<DIV >As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable <DIV></DIV></DIV>Crosslay Remedies LimitedMr. Yogesh SharmaKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee110000000<DIV >As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable <DIV></DIV></DIV>Crosslay Remedies LimitedDr. Gaurav AggarwalKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee460000000<DIV > <DIV></DIV>As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable</DIV>Crosslay Remedies LimitedDr Sowjanya AgarwalRelative of Key Managerial PersonAny other transactionProfessional Consultancy FeeAs per approval given by Audit & Risk Management Committee5400000400000800000<DIV >As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable <DIV></DIV></DIV>Crosslay Remedies LimitedMr. Navneet MainiIndependent DirectorAny other transactionDirector's sitting feeAs per approval given by Audit & Risk Management Committee0200000<DIV >As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable <DIV></DIV></DIV>Crosslay Remedies LimitedMr. Girish NarangIndependent DirectorAny other transactionDirector's sitting feeAs per approval given by Audit & Risk Management Committee100000200000<DIV >As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable <DIV></DIV></DIV>Hometrail Buildtech Private LimitedMr. Pawan KhuranaKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee90000000<DIV >As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable <DIV></DIV></DIV>Hometrail Buildtech Private LimitedMr. Utsav SainiKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee110000000<DIV > <DIV>As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable</DIV></DIV>Hometrail Buildtech Private LimitedMr. Pinak MoudgilDirectorAny other transactionSecurity Deposit received as per Company's car policy for employeesAs per approval given by Audit & Risk Management Committee019000001900000<DIV > <DIV></DIV>As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable</DIV>Hometrail Buildtech Private LimitedMr. Pinak MoudgilDirectorRemunerationAs per approval given by Audit & Risk Management Committee460000000<DIV >As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable <DIV></DIV></DIV>Max Hospitals And Allied Services LimitedRadiant Life Care Private LimitedEntities under same Group/common controlAny other transactionLease rent expense100000As per approval given by Audit & Risk Management Committee500002000010000<DIV > <DIV>Max Hospitals and Allied Services Limited got converted into Public Company w.e.f. April 13, 2022 and its name was changed from Radiant Life Care Mumbai Private Limited to Max Hospital and Allied Services Private Limited w.e.f. March 24, 2022.</DIV></DIV>Max Hospitals And Allied Services LimitedRadiant Life Care Private LimitedEntities under same Group/common controlAny other transactionReimbursement of electricity and other expenses10000As per approval given by Audit & Risk Management Committee1000000<DIV > <DIV>Max Hospitals and Allied Services Limited got converted into Public Company w.e.f. April 13, 2022 and its name was changed from Radiant Life Care Mumbai Private Limited to Max Hospital and Allied Services Private Limited w.e.f. March 24, 2022.</DIV> <DIV></DIV></DIV>Max Hospitals And Allied Services LimitedMs. Prachi Singh (Resigned on 30.04.2022)Key Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee30000000<DIV > <P>1. As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable.</P> <DIV>2. Max Hospitals and Allied Services Limited got converted into Public Company w.e.f. April 13, 2022 and its name was changed from Radiant Life Care Mumbai Private Limited to Max Hospital and Allied Services Private Limited w.e.f. March 24, 2022.</DIV></DIV>Max Hospitals And Allied Services LimitedMr. Surjeet Singh RathoreKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee80000000<DIV > <DIV></DIV> <P>1. As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable.</P> <DIV>2. Max Hospitals and Allied Services Limited got converted into Public Company w.e.f. April 13, 2022 and its name was changed from Radiant Life Care Mumbai Private Limited to Max Hospital and Allied Services Private Limited w.e.f. March 24, 2022.</DIV></DIV>Max Hospitals And Allied Services LimitedMs. Ashwini PandhareKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee190000000<DIV > <P>1. As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable.</P> <DIV>2. Max Hospitals and Allied Services Limited got converted into Public Company w.e.f. April 13, 2022 and its name was changed from Radiant Life Care Mumbai Private Limited to Max Hospital and Allied Services Private Limited w.e.f. March 24, 2022.</DIV> <P>&nbsp;</P> <DIV></DIV></DIV>Max Hospitals And Allied Services LimitedMr. Sidharth Sharma (appointed w.e.f. 02.05.2022 and resigned on 28.07.2022)Key Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee30000000<DIV > <P>1. As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable.</P> <DIV>2. Max Hospitals and Allied Services Limited got converted into Public Company w.e.f. April 13, 2022 and its name was changed from Radiant Life Care Mumbai Private Limited to Max Hospital and Allied Services Private Limited w.e.f. March 24, 2022.</DIV></DIV>Max Hospitals And Allied Services LimitedMr. Rahul Kapur (appointed w.e.f. 29.08.2022)Key Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee10000000<DIV > <DIV>1. As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable.</DIV> <DIV>&nbsp;</DIV> <DIV> <DIV>2. Max Hospitals and Allied Services Limited got converted into Public Company w.e.f. April 13, 2022 and its name was changed from Radiant Life Care Mumbai Private Limited to Max Hospital and Allied Services Private Limited w.e.f. March 24, 2022.</DIV></DIV> <DIV>&nbsp;</DIV></DIV>Max Lab LimitedMr. Ashish BhatiaKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee670000000Saket City Hospitals LimitedMr. Soubir GhoshKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee90000000<DIV >As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable <DIV></DIV></DIV>Saket City Hospitals LimitedMs. Poonam MakkarKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee120000000<DIV >As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable <DIV></DIV></DIV>Saket City Hospitals LimitedMs. Poonam MakkarKey Managerial PersonnelAny other transactionSecurity Deposit received as per Company's car policy for employeesAs per approval given by Audit & Risk Management Committee0500000500000<DIV > <DIV></DIV>As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable</DIV>Saket City Hospitals LimitedDr. Sahar QureshiKey Managerial PersonnelAny other transactionSecurity Deposit received as per Company's car policy for employeesAs per approval given by Audit & Risk Management Committee00100000<DIV > <DIV></DIV>As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable</DIV>Saket City Hospitals LimitedDr. Sahar QureshiKey Managerial PersonnelRemunerationAs per approval given by Audit & Risk Management Committee120000000<DIV > <DIV></DIV>As per approval given by Nomination &amp; Remuneration Committee/Board of Directors/Shareholders, as may be applicable</DIV>Dr. Balabhai Nanavati HospitalRadiant Life Care Private LimitedEntities under same Group/common controlAny other transactionLease rent expense1400000As per approval given by Audit & Risk Management Committee60000000Dr. Balabhai Nanavati HospitalRadiant Life Care Private LimitedEntities under same Group/common controlAny other transactionReimbursement of electricity and other expenses100000As per approval given by Audit & Risk Management Committee10000000Dr. Balabhai Nanavati HospitalMr. Aditya soiRelative of controlling personRemuneration18100000As per approval given by Audit & Risk Management Committee90000008000001100000